<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16740">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02047409</url>
  </required_header>
  <id_info>
    <org_study_id>EDT-13001-PD</org_study_id>
    <secondary_id>2013/07651-7</secondary_id>
    <secondary_id>2010/50048-1</secondary_id>
    <nct_id>NCT02047409</nct_id>
  </id_info>
  <brief_title>Prognostic Value of Sympathetic Modulation in Patients With Heart Failure</brief_title>
  <official_title>Prognostic Value of Oscillatory Pattern of Sympathetic Nerve Activity Muscle in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>InCor Heart Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fundação de Amparo à Pesquisa do Estado de São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether oscillatory pattern of sympathetic nerve
      activity muscle is an efficient index for the prognosis of patients with heart failure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Peripheral autonomic control</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Evaluate if the reduction in the oscillatory pattern of muscle sympathetic nerve activity is associated with morbidity and mortality in patients with heart failure in a clinical follow-up 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Arterial baroreflex control</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood inflammatory markers</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac and peripheral autonomic control</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Capacity</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Heart Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The sample consisted of patients with heart failure in clinical follow up at the Heart
        Institute (InCor), University of São Paulo, School of Medicine.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with systolic heart failure and New York Heart Association (NYHA)

          -  Ischemic, hypertensive, or idiopathic etiology

          -  Left ventricular ejection fraction less than 40%

        Exclusion Criteria:

          -  Neuromuscular, Orthopedic, Neurologic and Pulmonary Diseases

          -  Renal failure

          -  Diabetes mellitus type II
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Edgar Toschi Dias, PhD</last_name>
    <phone>55 11 2661-5099</phone>
    <email>edgar.dias@incor.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Urbana P B Rondon, PhD</last_name>
    <phone>55 11 3091-8784</phone>
    <email>urbana@usp.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Institute (InCor), University of Sao Paulo, School of Medicine.</name>
      <address>
        <city>São Paulo</city>
        <zip>05403-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edgar Toschi Dias, PhD</last_name>
      <phone>55 11 2661-5099</phone>
      <email>edgar.dias@incor.usp.br</email>
    </contact>
    <contact_backup>
      <last_name>Maria Urbana P B Rondon, PhD</last_name>
      <phone>55 11 3091-8784</phone>
      <email>urbana@usp.br</email>
    </contact_backup>
    <investigator>
      <last_name>Carlos Eduardo Negrão, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Urbana P B Rondon, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Janieire N N Alves, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>January 27, 2014</lastchanged_date>
  <firstreceived_date>January 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
